All articles tagged with #health and medicine
A new study suggests a blood test measuring plasma biomarkers could detect Alzheimer’s disease decades before symptoms emerge, supporting the idea that the illness may begin in midlife and is linked to cognitive differences, with potential to enable earlier diagnosis and help prevent or delay dementia.
A Global Burden of Disease 2023 analysis published in The Lancet finds chronic kidney disease affects about 14% of adults worldwide—roughly 788 million people in 2023—pushing CKD into the top 10 causes of death and making it a major driver of cardiovascular disease. Most cases are early, so early detection and access to treatments (dialysis, transplantation, and newer kidney‑protective therapies) are crucial, yet access remains uneven in low‑income regions. The study calls for expanded screening and better treatment access to slow progression and reduce heart‑related risk as CKD policies gain global prominence.
A small randomized trial (n=30) tested tocilizumab, an IL-6 blocker used for inflammatory diseases, in treatment-resistant depression with signs of inflammation. Participants receiving the drug showed greater improvement in depression, fatigue, anxiety, and quality of life, with a higher remission rate (54% vs. 31%) and an NNT of 5, suggesting a potential immune-based approach to treating depression, though larger phase III trials are needed to confirm efficacy and safety.
NIH-funded Nature study shows oral small-molecule GLP-1 weight-loss drugs can access a deep-brain reward circuit, activating the central amygdala and reducing dopamine release during pleasure-driven eating, potentially dampening hedonic cravings beyond hunger and hinting at uses in addiction; further research is needed to confirm effects in humans and across substances as access to these meds grows.
A UVM PhD candidate physician studies how a Western-style diet with binge drinking accelerates fatty liver disease using a mouse model that mirrors human patterns; findings show rapid progression from fatty liver to inflammatory disease within about 12 weeks, especially in males, with no FDA-approved treatment—emphasizing prevention through food-system changes like greater access to minimally processed foods and reduced high-sugar products, while also exploring sex differences and dietary fat sources. The work underscores a systems-level approach to a medical problem and has earned the Graduate Research Excellence Award.
A mouse study found the anti-aging drug combo dasatinib plus quercetin (D+Q) caused dramatic myelin loss in the brain, with younger mice more affected and the corpus callosum deteriorating. Damaged oligodendrocytes appeared to revert to a juvenile, less functional state resembling cells seen in multiple sclerosis, offering new MS clues while highlighting potential brain risks of senolytic therapies and cautioning off-label use.
A University of Turku study using PET and MRI found no evidence of widespread brain inflammation in long COVID patients compared with healthy controls. Inflammation may be higher earlier after infection and fade over time. More severe symptoms correlated with increased activity in emotion-related regions (hippocampus and amygdala), suggesting treatments focusing on stress management and emotional regulation rather than solely anti-inflammatory approaches.
Japanese researchers developed vitamin K analogs linked to retinoic acid that threefold boost the differentiation of neural progenitor cells into neurons and cross the blood–brain barrier in mice, increasing brain MK-4 levels; this points to a regenerative approach for diseases like Alzheimer's and Parkinson’s, though human trials are not yet underway.
A Lancet study finds about 1.2 billion people had mental health disorders in 2023, a 95.5% rise since 1990, with anxiety up 158% and depression up 131% across 204 countries. Mental health conditions now account for the largest share of global disability, yet government spending on mental health averages only around 2% of health budgets, and roughly 9% of people with depression receive minimally adequate treatment. The report highlights a surge among youth (15–19 age group) and calls for stronger global leadership, expanded mental-health services, and attention to lifestyle factors like sleep and social connection to address this mounting crisis.
USC researchers identified selective inhibitors of the brain inflammation enzyme cPLA2 that may lower Alzheimer’s risk, especially for APOE4 carriers; the compounds cross the blood-brain barrier, showed activity in brain cells and mouse models, and represent a promising but early-stage drug discovery path with safety and feasibility in humans to be determined.
Duke University researchers showed that damaged nerves can be revived by transferring healthy mitochondria from glial cells to sensory neurons, significantly reducing pain in models of diabetic and chemotherapy-induced neuropathy and suggesting a new way to treat chronic pain at its source. More studies are required to understand the mechanism and validate this approach in humans.
An international study of nearly 500 cat tumors finds shared cancer-causing genes with human cancers, including FBXW7 mutations in feline mammary tumors, suggesting human therapies could be adapted for cats and advancing a One Medicine approach to cancer research.
Dozens of hikers on California’s portion of the Pacific Crest Trail have fallen ill with a norovirus outbreak, with 7–12 confirmed cases reported near Wrightwood in San Bernardino County. Norovirus is highly contagious and causes vomiting and diarrhea; health officials urge thorough handwashing, cleaning of contaminated surfaces, and avoiding food preparation for a few days after recovery as thousands continue to trek the trail each year.
UC Davis researchers found that adding bananas to berry smoothies dramatically reduces flavanol absorption due to the PPO enzyme—banana smoothies showed about 84% lower flavanol levels than a control; pairing flavanol-rich ingredients with low-PPO foods (e.g., mango, pineapple, orange, yogurt) may preserve flavanols.
A meta-analysis and related studies flag that vitamin D2 supplements can lower circulating vitamin D3, the more effective form, while vitamin D3 appears to better support immune function. The findings prompt consideration that D3 could be the preferred supplement for most people, though individual needs and further research remain important.